NDC | 0135-0607-01, 0135-0607-02, 0135-0607-03 |
Set ID | f626ab17-01c9-4493-ba9e-0c8c11146384 |
Category | HUMAN OTC DRUG LABEL |
Packager | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Generic Name | |
Product Class | alpha-1 Adrenergic Agonist |
Product Number | |
Application Number | PART341 |
- Active ingredients (in each caplet)
- Purposes
- Uses
-
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
- •
- more than 4,000 mg of acetaminophen in 24 hours, which is the maximum daily amount
- •
- with other drugs containing acetaminophen
- •
- 3 or more alcoholic drinks every day while using this product
Allergy alert: Acetaminophen may cause severe skin reactions.
Symptoms may include:
- •
- skin reddening
- •
- blisters
- •
- rash
If a skin reaction occurs, stop use and seek medical help right away.
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea or vomiting, ask a doctor promptly.
Do not use
- •
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- •
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
- •
- if you are allergic to acetaminophen or any of the inactive ingredients in this product
Ask a doctor before use if you have
- •
- liver disease
- •
- diabetes
- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- trouble urinating due to an enlarged prostate gland
-
Directions
- •
- do not take more than directed (see overdose warning)
- •
- adults and children 12 years of age and over: take 2 caplets every 4 hours, while symptoms persist or as directed by a doctor
- •
- do not take more than 12 caplets in 24 hours, unless directed by a doctor
- •
- children under 12 years of age: ask a doctor
- •
- swallow whole – do not crush, chew or dissolve
- Other information
- Inactive ingredients
-
Principal Display Panel
NDC 0135-0607-02
Panadol®
COLD+FLU
NON-DROWSY
ACETAMINOPHEN
Pain Reliever/Fever Reducer
PHENYLEPHRINE HCl
Nasal Decongestant
NEW FORMULA AND DIRECTIONS
24 CAPLETS
TAMPER-EVIDENT FEATURE: This product is protected in a sealed blister. Do not use if blister or printed foil is broken.
READ AND KEEP CARTON FOR COMPLETE INFORMATION
Trademarks are owned by or licensed to the GSK group of companies.
©2017 GSK group of companies or its licensor. All rights reserved.
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
30108XE
-
INGREDIENTS AND APPEARANCE
PANADOL COLD AND FLU NONDROWSY
acetaminophen and phenyleprine hcl tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0135-0607 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN 325 mg PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE 5 mg Inactive Ingredients Ingredient Name Strength ACESULFAME POTASSIUM (UNII: 23OV73Q5G9) CARNAUBA WAX (UNII: R12CBM0EIZ) CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK) D&C YELLOW NO. 10 (UNII: 35SW5USQ3G) FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C RED NO. 40 (UNII: WZB9127XOA) LECITHIN, SOYBEAN (UNII: 1DI56QDM62) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990) POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) STARCH, CORN (UNII: O8232NY3SJ) STEARIC ACID (UNII: 4ELV7Z65AP) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color GREEN Score no score Shape OVAL (caplet) Size 16mm Flavor VANILLA Imprint Code CF Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0135-0607-03 50 in 1 CARTON 06/01/2017 1 NDC:0135-0607-01 2 in 1 PACKET; Type 0: Not a Combination Product 2 NDC:0135-0607-02 3 in 1 CARTON 06/01/2017 2 8 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 06/01/2017 Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)